Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer

Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan Liposome; Drug: 5-FU; Drug: LV; Drug: Bevacizumab Sponsors: West China Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials